Animal studies showed that a loss-of-function mutation of the circadian clock genes, such as Clock and Arntl, may result in metabolic abnormalities of lipid and glucose homeostasis, hallmarks of MetS [5, 6]. This evidence concerns the gene BMAL1 and metabolic syndrome.